Coherus Oncology, Inc. (CHRS)
1.07
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
1.075
0.00 (0.00%)
After-Hours: 20:00
Coherus Oncology Market Cap : 165.28M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 165.28M |
| October 08, 2026 | 165.28M |
| October 07, 2026 | 156.02M |
| October 06, 2026 | 159.10M |
| October 05, 2026 | 173.01M |
| October 02, 2026 | 179.19M |
| October 01, 2026 | 179.19M |
| September 30, 2026 | 186.91M |
| September 29, 2026 | 182.28M |
| September 28, 2026 | 176.10M |
| September 25, 2026 | 174.55M |
| September 24, 2026 | 180.73M |
| September 23, 2026 | 194.63M |
| September 22, 2026 | 200.81M |
| September 21, 2026 | 211.62M |
| September 18, 2026 | 208.54M |
| September 17, 2026 | 190.00M |
| September 16, 2026 | 188.45M |
| September 15, 2026 | 205.45M |
| September 14, 2026 | 220.89M |
| September 11, 2026 | 205.45M |
| September 10, 2026 | 206.99M |
| September 09, 2026 | 203.90M |
| September 08, 2026 | 211.62M |
| September 04, 2026 | 219.35M |
| Date | Value |
|---|---|
| September 03, 2026 | 211.62M |
| September 02, 2026 | 219.35M |
| September 01, 2026 | 211.62M |
| August 31, 2026 | 208.54M |
| August 28, 2026 | 217.80M |
| August 27, 2026 | 225.53M |
| August 26, 2026 | 223.98M |
| August 25, 2026 | 211.62M |
| August 24, 2026 | 210.08M |
| August 21, 2026 | 219.35M |
| August 20, 2026 | 203.90M |
| August 19, 2026 | 205.45M |
| August 18, 2026 | 206.99M |
| August 17, 2026 | 177.64M |
| August 14, 2026 | 185.36M |
| August 13, 2026 | 176.10M |
| August 12, 2026 | 180.73M |
| August 11, 2026 | 186.91M |
| August 10, 2026 | 191.54M |
| August 07, 2026 | 196.18M |
| August 06, 2026 | 195.41M |
| August 05, 2026 | 223.98M |
| August 04, 2026 | 228.62M |
| August 03, 2026 | 222.44M |
| July 31, 2026 | 217.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enanta Pharmaceuticals, Inc. | 364.00M |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.011B |
Market Cap Related Metrics
| PS Ratio | 2.772 |
| Price to Book Value | 2.717 |
| Price | 1.07 |
| Earnings Yield | -95.44% |